{"version":"1.0","type":"link","title":"Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor.","author_name":"Xie L 외","author_url":"https://prs-insight.online/author/Xie%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/98434","thumbnail_width":1200,"thumbnail_height":630}